
Healthcare Capital Markets & Innovation Summit (HCMIS)
🎯 Selling to this event's audience? Get a free tailored buyer list
Tell us your work email and our AI instantly builds a buyer list matched to Healthcare Capital Markets & Innovation Summit (HCMIS) — the best‑fit companies to target, the exact decision‑maker job titles, and the industry filters that fit what you sell.
About this event
Healthcare Capital Markets & Innovation Summit (HCMIS)
The Healthcare Capital Markets & Innovation Summit is best understood as a high-value investment, strategy, innovation, and healthcare business development event. This is not a broad consumer healthcare conference. It is a specialized gathering where investors, executives, finance leaders, growth-stage healthcare companies, strategic acquirers, innovation teams, and sector advisors come together to evaluate trends, fundraising, deal flow, partnerships, commercialization, and market expansion across healthcare.
For attendee-list sales, this event is especially attractive when the target is decision-makers with purchasing power, investment authority, partnership responsibility, or strategic influence. The most valuable contacts are not just general attendees, but the people who control budgets, evaluate vendors, source opportunities, manage innovation portfolios, and make capital allocation decisions. Because of that, this event can be a strong source for B2B lead generation if your client sells services, technology, financial tools, advisory solutions, data products, healthcare infrastructure, or innovation-enablement offerings.
Before finalizing the buyer list for your client, please share your client website or company name. That will let me match the event audience to the right buying profiles more accurately and identify the best-fit target accounts based on the client’s product, service category, and ideal customer profile.
1️⃣ Who attends: Buyers / Attendees
This summit is typically attended by a mix of capital markets professionals and healthcare industry operators. The attendee base is likely to include people who are actively involved in funding, scaling, acquiring, advising, or innovating within healthcare organizations. The core audience is usually senior-level, commercially focused, and highly network-oriented.
Main attendee groups:
- Private equity investors focused on healthcare services, medtech, pharma services, and digital health
- Venture capital investors funding early-stage healthcare innovation
- Investment bankers, M&A advisors, and capital markets analysts
- CFOs, CEOs, and corporate development leaders from healthcare companies
- Founders and executives of growth-stage healthcare startups
- Hospital and health system executives exploring partnerships, acquisitions, and modernization strategies
- Digital health, biotech, medtech, diagnostics, and healthcare IT leaders
- Consultants, legal advisors, accountants, and compliance specialists serving healthcare transactions
- Institutional investors, family offices, and strategic investment groups
- Innovation officers, commercialization leaders, and venture studio teams
In practical buyer terms, this event is strongest for targeting people who influence: funding decisions, vendor selection, platform adoption, healthcare expansion, transaction support, and strategic growth partnerships.
2️⃣ Where the show is happening + attendee geographic origin
The exact venue details were not provided in your prompt, so this section should be finalized once the official event location is confirmed. Based on the summit title, HCMIS is likely to attract a major metropolitan U.S. audience, often in a financial or healthcare hub such as New York, Boston, Chicago, San Francisco, Dallas, Nashville, or Miami.
Attendee geographic origin: This type of summit typically has a national and global attendee mix. Most participants will likely come from the United States, but it can also attract international investors, global healthcare strategists, multinational medtech companies, and cross-border advisory firms.
Best geographic targeting:
- U.S. national audience, especially major healthcare and finance hubs
- Regional concentration around the host city and surrounding states
- Global participation from investors, strategists, and companies with U.S. market interest
- Cross-border healthcare innovators and firms exploring U.S. capital access
If the venue is in a major U.S. city, the event likely benefits from strong inbound travel from both healthcare corridors and capital markets centers. If the event is tied to a specific region, the audience may be more concentrated but still commercially valuable.
3️⃣ Audience reach: Local / National / Global
Reach type: National with strong global relevance
HCMIS is best categorized as a national-level business summit with global relevance. The core audience is likely U.S.-based because healthcare capital markets, investment activity, reimbursement strategy, and healthcare commercialization are heavily driven by the U.S. ecosystem. However, the subject matter is inherently international because healthcare investment, innovation, and deal flow are global industries.
If the summit includes venture capital, private equity, digital health, medtech, or biotech content, then the audience reach becomes even broader. In that case, the event will likely attract:
- U.S. and international investors
- Healthcare startups seeking capital and partnerships
- Strategic acquirers looking for pipeline and technology access
- Advisors and service providers supporting healthcare transactions
- Innovation ecosystem stakeholders from multiple regions
4️⃣ Sample buyer company names + websites
Below is a sample buyer table with companies that are highly relevant for HCMIS. These are not random names; they represent likely buyers, sponsors, partners, investors, or strategic account targets for healthcare capital markets and innovation audiences. The “best title to target” column focuses on the people who would most likely engage with attendee data, sponsorship opportunities, or event outreach.
| Priority | Company | Website | Best Title to Target | Why This is a Good Buyer Fit |
|---|---|---|---|---|
| 1 | Blackstone Life Sciences | blackstone.com | Managing Director, Life Sciences / Investment Director | Strong fit for healthcare investing, growth capital, and strategic partnerships. |
| 2 | Oak HC/FT | oakhcft.com | Partner / Principal / Head of Platform | Focused on healthcare and fintech innovation with active deal sourcing needs. |
| 3 | General Catalyst | generalcatalyst.com | Partner, Health Assurance / Investor | Invests heavily in healthcare transformation and digital health innovation. |
| 4 | NEA | nea.com | Partner, Healthcare / Investment Associate | Major healthcare and life sciences investor with strong conference alignment. |
| 5 | CVS Health | cvshealth.com | Corporate Development Director / Innovation VP | Large healthcare enterprise with acquisition, innovation, and partnership interests. |
| 6 | UnitedHealth Group | unitedhealthgroup.com | VP Corporate Development / Strategic Partnerships Director | Large payer-provider ecosystem player with strong innovation and growth mandate. |
| 7 | Pfizer | pfizer.com | Business Development Director / Innovation Partnerships Lead | Relevant for life sciences innovation, partnering, and market expansion themes. |
| 8 | Moderna | modernatx.com | Strategic Finance Director / Corporate Strategy Lead | Highly innovation-driven healthcare company with capital allocation and growth needs. |
| 9 | HCA Healthcare | hcahealthcare.com | Vice President, Strategy / Corporate Development Manager | Hospital system with M&A, service-line, and digital transformation priorities. |
| 10 | McKesson | mckesson.com | VP Strategy / Business Development Director | Healthcare distribution and services leader with strategic growth and platform interests. |
| 11 | CVS Ventures / Health Innovation Team | cvshealth.com | Innovation Manager / Venture Partner / Strategy Director | Strong interest in new healthcare technologies and commercial partnerships. |
| 12 | Rock Health | rockhealth.com | Partner / Research Lead / Program Director | Digital health ecosystem player with strong market intelligence and founder access. |
| 13 | BlueCross BlueShield Association | bcbs.com | Director, Innovation Strategy / Market Development Lead | Payer-side innovation and healthcare economics are relevant to summit content. |
| 14 | Mount Sinai Health System | mountsinai.org | VP Innovation / Director of Strategic Partnerships | Academic medical center with commercialization and innovation collaboration needs. |
| 15 | Mercy | mercy.net | Chief Strategy Officer / VP Innovation | Healthcare delivery organization likely to engage on digital transformation and capital strategy. |
Top 5 best samples to send first: Blackstone Life Sciences, Oak HC/FT, General Catalyst, NEA, and CVS Health. These names represent a healthy mix of investor, strategic buyer, and enterprise innovation profiles.
5️⃣ Job profiles, industries & event type
This event is best targeted at senior commercial, strategic, and financial roles. The attendee list should prioritize people with budget influence, investment responsibility, deal-making authority, or innovation ownership.
Best job profiles to target:
- Managing Partner
- Partner / Principal
- Investment Director
- Investment Associate
- VP Corporate Development
- Director of Strategy
- Chief Financial Officer
- Chief Strategy Officer
- Chief Innovation Officer
- VP Innovation
- Director, Business Development
- Head of Partnerships
- Growth Equity Investor
- Portfolio Operations Leader
- Healthcare M&A Advisor
- Healthcare Technology Scout
- Digital Health Partnerships Lead
- Corporate Venture Capital Manager
Best industries to use from your industry list:
- Financial Services
- Investment Banking
- Investment Management
- Venture Capital & Private Equity
- Capital Markets
- Hospital & Health Care
- Pharmaceuticals
- Biotechnology
- Medical Devices
- Health, Wellness & Fitness
- Information Technology & Services
- Computer Software
- Market Research
- Management Consulting
- Insurance
- Research
- Healthcare-related advisory, services, and innovation categories
Event type: Healthcare capital markets, investment summit, innovation conference, strategy forum, deal-flow and partnership event.
6️⃣ Estimated attendance / expected footfall
Because HCMIS is a specialist summit, the likely attendance is smaller than a large national tradeshow but significantly more targeted and commercially valuable. Estimated total attendance is likely in the range of 400 to 1,500 attendees, depending on whether it is a boutique executive summit or a larger multi-track conference.
A practical planning estimate would be:
- Executive summit format: 300–600 attendees
- Mid-size conference format: 600–1,200 attendees
- Expanded summit with sponsors and exhibits: 1,200–1,500+ attendees
Footfall should not be judged only by volume. For this event, the real value lies in attendee quality. Even a smaller crowd can be extremely valuable if the mix includes investors, executives, strategists, and healthcare growth leaders.
7️⃣ Key focus areas & buyer engagement
Key focus areas likely include:
- Healthcare investing and fund performance
- Private equity and venture capital in healthcare
- M&A, roll-ups, consolidation, and strategic acquisitions
- Digital health, health tech, and AI in healthcare
- Provider transformation and value-based care economics
- Biotech and medtech commercialization
- Revenue cycle, care delivery optimization, and operational scale
- Innovation funding and go-to-market strategy
- Market intelligence and sector outlook
- Partnership building between investors, operators, and founders
Buyer engagement opportunities: The best engagement strategy for HCMIS is to position the attendee list as a pipeline of:
- Healthcare investors
- Corporate development leaders
- Strategy and innovation executives
- Founder and growth-stage decision-makers
- Advisors supporting transactions and commercialization
The strongest value proposition is not “general healthcare leads,” but rather: senior buyers with budget authority and strategic relevance in healthcare growth, funding, commercialization, and partnerships.
8️⃣ Client product fit note
To recommend the best buyers for your client, I need your client’s website or at least the product/service category. This is essential because the right audience segment changes significantly based on what the client sells.
Examples:
- If the client sells market intelligence, data, or research, target investors, strategy teams, and corporate development leaders.
- If the client sells event tech, CRM, or attendee management tools, target summit organizers, healthcare associations, and innovation teams.
- If the client sells consulting or advisory services, target private equity firms, healthcare operators, and growth-stage companies.
- If the client sells healthcare software or AI solutions, target hospitals, payers, digital health firms, and portfolio companies.
- If the client sells recruiting, staffing, or business development services, target corporate development, HR, and partnership leaders across healthcare firms.
Please share the client website, and I can narrow this down to the most relevant buyers, titles, and industries with much higher precision.
9️⃣ Final recommendation
HCMIS is a strong event for attendee-list sales if your goal is to reach a high-value, executive-level healthcare business audience. It is not a mass-market healthcare event; it is a commercially focused summit that should deliver better-than-average lead quality if the list is filtered correctly.
Best buyer segments to prioritize:
- Private equity and venture capital professionals
- Corporate development and strategy leaders
- Healthcare founders and CEOs
- Innovation and partnerships leaders
- Healthcare advisors, analysts, and growth operators
Quality rating for B2B attendee-list sales: 8.5/10
This is a strong event because the audience is commercially relevant, senior, and highly aligned with healthcare growth, investment, and innovation themes. The only limitation is that the exact buyer fit depends heavily on the client’s offering. Once you share the client website, I can produce a much more targeted buyer shortlist and help you identify the highest-probability contacts.
Data sheet
| Event Name | Healthcare Capital Markets & Innovation Summit (HCMIS) |
| Event Date | June 3, 2026 – June 4, 2026 |
| Event Status | Completed |
| Venue | Columbus, USA |
| City | Columbus |
| State / Region | Ohio |
| Country | United States |
| Organizer | Organizer not publicly confirmed in current research scope. |
| Official Event Website | Official event website not publicly verified in current research scope. |
| Event Type | Healthcare investment, capital markets, innovation, and strategic growth summit |
| Primary Category | Banking & Finance |
| Secondary Applicable Categories | Medical & Pharma; IT & Technology; Business Services |
| Audience Reach | Likely national with selective regional and investor-network reach |
| Estimated Attendance / Expected Footfall | Attendance figure not publicly confirmed by the organizer. |
| Attendance Data Reliability | Low for numeric counts; event theme and attendee profile are directionally reliable based on the event name and supplied event description. |
| Main Purpose of Event | To connect healthcare investors, executives, innovation leaders, growth-stage companies, strategic partners, and advisory stakeholders around fundraising, deal sourcing, commercialization, partnerships, and market expansion. |
Healthcare Capital Markets & Innovation Summit (HCMIS) is best positioned as a specialized business event focused on healthcare investment, strategic growth, innovation partnerships, and capital access rather than a broad clinical or consumer-health conference. Based on the event title and supplied description, the summit is designed to attract executive-level participants involved in financing, commercialization, partnerships, corporate strategy, and healthcare business development.
From a lead generation standpoint, HCMIS is potentially valuable because the likely audience includes budget owners, innovation sponsors, transaction-oriented leaders, and senior decision-makers who influence vendor selection, capital allocation, and strategic partnerships. This makes the event relevant for firms selling financial services, advisory services, growth enablement, market intelligence, healthcare technology, data products, commercialization support, and enterprise services into the healthcare ecosystem.
| Buyer / Attendee Segment | Typical Organizations | Buying Role or Influence | Relevance to Exhibitors / Suppliers |
|---|---|---|---|
| Healthcare investors | Venture capital firms, private equity firms, healthcare-focused funds, family offices | Evaluate investment opportunities, diligence vendors, assess market signals | High relevance for intelligence providers, diligence firms, legal, accounting, data, and technology platforms |
| Corporate strategy and M&A leaders | Large healthcare companies, payers, providers, medtech, pharma, health IT groups | Source acquisition targets, partnerships, innovation pilots, and market-entry opportunities | Relevant for market expansion, advisory, valuation, integration, and commercial strategy services |
| Healthcare company executives | Growth-stage healthcare startups, established healthcare operators, service providers | Control budgets for platforms, consulting, commercialization, partnerships, and growth tools | Strong fit for enterprise vendors selling software, data, operations, marketing, and strategic services |
| Finance leaders | CFO offices, corporate development teams, treasury, investor relations groups | Influence vendor spend tied to fundraising, reporting, analytics, and transaction support | High-value audience for financial tools, audit, tax, compliance, and capital advisory suppliers |
| Innovation and digital health leaders | Innovation labs, digital transformation teams, incubators, health systems, health tech companies | Assess pilots, partnerships, transformation initiatives, and vendor solutions | Relevant for software, interoperability, analytics, AI, workflow, and patient engagement offerings |
| Business development and partnership teams | Healthcare service firms, health IT vendors, manufacturers, advisory firms | Source channel partners, enterprise clients, strategic alliances, and co-development opportunities | Useful for outbound sales, referral partnerships, and ecosystem mapping |
| Commercialization and growth teams | Scale-ups, incubated ventures, commercialization agencies, healthcare product companies | Need go-to-market support, channel introductions, regulatory path guidance, and growth services | Strong fit for PR, market access, distribution, sales enablement, and demand generation suppliers |
| Advisors and service intermediaries | Investment banks, law firms, accounting firms, consulting firms, valuation firms | Influence purchasing and introductions across portfolios and transaction pipelines | High networking value; often multipliers for referrals and ecosystem access |
| Geographic Area | Likely Attendee Origin | Buyer Concentration | Notes |
|---|---|---|---|
| Columbus | Local healthcare, finance, startup, and innovation ecosystem participants | Moderate | Likely source of operators, startup founders, local investors, advisors, and health system stakeholders |
| Ohio | Regional healthcare executives, provider groups, investors, service firms, innovation networks | High | Ohio is a practical catchment area for hospital systems, digital health companies, and regional capital providers |
| Midwest business hubs | Cleveland, Cincinnati, Indianapolis, Chicago, Pittsburgh, Detroit, Nashville-linked attendees | High | Likely to include healthcare service operators, private capital, and commercialization partners |
| United States | National investor, health tech, and strategic healthcare attendees | High | Summit format and capital-markets theme suggest a broader U.S. decision-maker audience rather than purely local footfall |
| International | Selective, not publicly confirmed | Low to Moderate | Possible for investors, advisors, and cross-border healthcare capital participants, but not confirmed |
| Reach Level | Assessment | Explanation |
|---|---|---|
| National | Primary classification | The healthcare capital markets and innovation theme typically attracts U.S.-wide investors, healthcare executives, advisors, and growth-stage companies rather than mass local traffic. |
| Regional | Secondary relevance | Ohio and the broader Midwest are likely meaningful feeder markets for attendance, partnerships, and healthcare innovation networks. |
| Buyer Company / Organization | Buyer Type | Why It Is Relevant | Website | Best Job Titles to Target | Evidence Level |
|---|---|---|---|---|---|
| Current-year participant list not publicly confirmed | Data limitation | No official current-year attendee, sponsor, speaker, or buyer organization list was publicly verified in current research scope. | N/A | N/A | Confirmed limitation |
| Data-sheet recommendation | Method note | Use HCMIS primarily as a seniority-led outbound targeting theme until official company-level participation evidence is available. | N/A | CFO, VP Corporate Development, Head of Innovation, Managing Director, Partner | Confirmed limitation |
| Priority | Job Title / Function | Department | Seniority Level | Why This Role Matters |
|---|---|---|---|---|
| 1 | Chief Executive Officer | Executive Office | C-Level | Primary budget owner and strategic decision-maker for partnerships, fundraising, and growth initiatives |
| 2 | Chief Financial Officer | Finance | C-Level | Controls capital planning, finance tooling, reporting, diligence, and transaction support spend |
| 3 | Managing Director / Investment Director / Partner | Investments | Partner / Executive | Key investment decision-makers for funds, strategic capital, and portfolio introductions |
| 4 | VP Corporate Development | Corporate Development | VP | Leads M&A, partnerships, strategic investments, and growth transactions |
| 5 | Director of Strategic Partnerships | Business Development | Director | Influences channel deals, co-selling, ecosystem expansion, and strategic vendor selection |
| 6 | Head of Innovation / Chief Innovation Officer | Innovation | Executive / VP | Sponsors pilots, digital transformation programs, and partnership-driven innovation |
| 7 | Director of Business Development | Business Development | Director | Owns pipeline generation, partnership evaluation, and commercial introductions |
| 8 | VP Strategy | Strategy | VP | Evaluates growth models, expansion opportunities, and long-range investment priorities |
| 9 | Investor Relations Director | Finance / IR | Director | Relevant for communications, reporting platforms, data services, and capital markets support |
| 10 | Program Manager, Innovation or Ventures | Innovation / Strategy | Manager | Supports pilot execution, partner management, and internal adoption of new solutions |
| Priority | Apollo Industry | Why It Fits the Event | Best Buyer Use Case |
|---|---|---|---|
| 1 | Hospital & Health Care | Core healthcare operators, systems, and care delivery organizations | Innovation programs, partnerships, finance tools, and enterprise healthcare services |
| 2 | Financial Services | Capital providers, structured finance firms, and healthcare investment intermediaries | Deal sourcing, diligence, advisory, and portfolio support |
| 3 | Venture Capital & Private Equity | Direct fit for healthcare investors and growth capital attendees | Pipeline intelligence, diligence services, data platforms, and executive network access |
| 4 | Biotechnology | Healthcare innovation and funding relevance | Commercialization, capital raising, strategic partnerships |
| 5 | Medical Devices | Common capital and innovation category within healthcare growth events | Go-to-market, channel partnerships, strategic funding |
| 6 | Pharmaceuticals | Strategic acquirers, licensing, and investment activity may be relevant | Partnering, licensing, capital strategy, market intelligence |
| 7 | Information Technology & Services | Relevant for digital health, analytics, interoperability, and enterprise support | Platform sales, implementation, integration, and transformation services |
| 8 | Computer Software | Strong fit where innovation and capital meet software-enabled healthcare models | Digital health tools, analytics, workflow automation, AI platforms |
| 9 | Insurance | Payers and health-plan stakeholders may attend or be relevant for partnerships | Cost containment, innovation pilots, member engagement, care management tools |
| 10 | Management Consulting | Advisory intermediaries commonly support deal flow and transformation | Transaction support, GTM strategy, operational improvement, market diligence |
| 11 | Investment Banking | Directly relevant for capital markets and transaction-oriented discussions | Fundraising, advisory, sell-side, buy-side, and strategic finance services |
| 12 | Research | Relevant for clinical innovation, translational research, and commercialization pathways | Licensing, spinouts, collaboration, evidence development |
| Metric | Figure | Status | Source / Basis | Notes |
|---|---|---|---|---|
| Estimated total footfall | Attendance figure not publicly confirmed by the organizer. | Unconfirmed | No official attendance statistic verified in current research scope | Do not use a numeric claim in sales messaging without organizer validation |
| Exhibitor count | Not publicly confirmed | Unconfirmed | Current-year exhibitor directory not verified | Summit format may rely more on sponsors, speakers, and networking than a large expo hall |
| Buyer count | Not publicly confirmed | Unconfirmed | No verified attendee segmentation published in current research scope | Buyer quality may be stronger than raw volume if the event is invitation-led or executive-focused |
| Speaker count | Not publicly confirmed | Unconfirmed | Current agenda or speaker roster not verified | Speaker organizations would be a strong proxy for target accounts once sourced |
| Sponsor count | Not publicly confirmed | Unconfirmed | Sponsor page not verified | Sponsors may include banks, law firms, accounting firms, growth services, and healthcare technology vendors |
| Historical attendance | Historical attendance not publicly confirmed in current research scope. | Unavailable | No verified prior-year statistics reviewed | Prior-year brochures or recap releases would improve forecasting accuracy |
| Focus Area | Typical Buyer Need | Buyer Engagement Opportunity | Relevant Supplier Offering |
|---|---|---|---|
| Capital raising | Access to investors, fundraising readiness, market positioning | Advisory introductions, investor data, pitch optimization, transaction support | Capital advisory, investor intelligence, financial communications, valuation support |
| Healthcare innovation | Validation of new technologies, pilot partners, innovation sourcing | Executive demos, proof-of-concept offers, partnership workshops | Digital health platforms, AI tools, interoperability, workflow software |
| M&A and strategic growth | Target identification, diligence, integration planning, market expansion | Confidential advisory meetings, corporate development networking | Deal sourcing data, consulting, legal, accounting, integration support |
| Commercialization | Go-to-market planning, adoption acceleration, buyer access | Channel partner introductions, market-entry planning, sales enablement | GTM services, market research, demand generation, partnership development |
| Financial operations and reporting | Forecasting, compliance, investor reporting, capital planning | CFO roundtables, product demos, finance workflow consultations | FP&A tools, accounting services, reporting software, data rooms |
| Partnership development | Strategic alliances, channel relationships, co-development | One-to-one matchmaking, venture partner outreach, executive networking | Ecosystem mapping, BD consulting, alliance management support |
| Healthcare data and analytics | Better decision support, due diligence, market insight, performance visibility | Data-led demos, benchmarking sessions, strategic analytics conversations | Market intelligence, analytics platforms, BI, predictive modeling tools |
| Factor | Assessment | Explanation |
|---|---|---|
| Buyer relevance | High | The event theme suggests concentration of strategic, financial, and innovation-oriented buyers with meaningful influence. |
| Decision-maker availability | High | Summit positioning indicates likely presence of executives, investment leaders, and partnership stakeholders rather than junior general attendees. |
| Data collection potential | Medium | Potentially strong if speaker, sponsor, or attendee materials exist, but current public verification is limited. |
| Apollo targeting potential | Very High | The audience can be modeled effectively by industry, seniority, department, and title in Apollo even without a confirmed attendee file. |
| Geographic targeting potential | High | Ohio, Midwest, and national U.S. healthcare capital networks provide practical target layers. |
| Best outreach approach | High | Executive-value outreach tied to fundraising, growth, diligence, commercialization, and partnership outcomes is most likely to resonate. |
| Overall lead quality | High | Quality is likely stronger than volume; this is a targeted B2B summit, not a mass-footfall expo. |
| Best use case | Very High | Best for outbound account targeting, executive networking lists, innovation-buyer profiling, and strategic partnership prospecting. |
| Limitations / risks | Medium | Publicly verified attendance counts and company-level current-year participation evidence were not available in current research scope. |
| Filter Type | Recommended Filters | Purpose |
|---|---|---|
| Apollo industries | Hospital & Health Care; Financial Services; Venture Capital & Private Equity; Biotechnology; Medical Devices; Pharmaceuticals; Information Technology & Services; Computer Software; Insurance; Management Consulting; Investment Banking; Research | Captures healthcare operators, healthcare innovators, capital providers, and transaction advisors |
| Departments | Executive; Finance; Corporate Development; Strategy; Business Development; Innovation; Partnerships; Investor Relations | Maps to actual decision centers likely represented at this summit |
| Seniority | Owner; Partner; C-Level; VP; Director; Head | Prioritizes budget holders and strategic influencers |
| Job titles | CEO, President, CFO, Managing Director, Partner, Investment Director, VP Corporate Development, Director Corporate Development, Chief Innovation Officer, Head of Innovation, VP Strategy, Director Strategy, Director Business Development, Director Strategic Partnerships, Investor Relations Director | Improves precision for healthcare capital and innovation stakeholders |
| Geography | United States; Ohio; Midwest states; major healthcare hubs including Chicago, Nashville, Indianapolis, Cleveland, Cincinnati, Pittsburgh, Boston, New York, San Francisco | Builds concentric outreach layers around likely attendance and capital concentration |
| Employee size | 11-50; 51-200; 201-500; 501-1000; 1001-5000; 5001+ | Includes startups, growth-stage firms, mid-market operators, and enterprise strategic buyers |
| Keywords | healthcare innovation, digital health, venture, private equity, capital markets, commercialization, strategic partnerships, corporate development, M&A, growth equity, health tech, investment | Creates thematic alignment with HCMIS audience intent |
| Technologies, if relevant | CRM, analytics, health IT, interoperability, AI, data management, telehealth, revenue cycle, care management | Useful if targeting digital health and healthcare transformation buyers |
| Revenue range, if relevant | $1M-$10M; $10M-$50M; $50M-$250M; $250M+ | Helps separate venture-backed growth firms from large strategic acquirers and operators |
| Company type | Private; Public; PE-backed; VC-backed; Nonprofit health systems where relevant | Supports segmentation by buying motion and capital maturity |
| Source | Type | What It Verified | Reliability |
|---|---|---|---|
| User-supplied event brief | Provided input | Event name, city, state, country, venue reference, dates, and directional event description | High for supplied fields; not a substitute for official organizer verification |
| Official organizer / event website | Primary source target | Organizer, official venue name, attendance counts, attendee lists, sponsor lists, speaker lists, and agenda should be confirmed here before making attendance claims | Highest, once verified |
| Official venue website | Primary / venue source target | Specific venue confirmation, room booking, and event calendar details if published | High, once verified |
| Official speaker, sponsor, exhibitor, or agenda pages | Primary source target | Company-level participation evidence for buyer profiling and account selection | High, once verified |
🎯 Selling to this event's audience? Get a free tailored buyer list
Tell us your work email and our AI instantly builds a buyer list matched to Healthcare Capital Markets & Innovation Summit (HCMIS) — the best‑fit companies to target, the exact decision‑maker job titles, and the industry filters that fit what you sell.